NYSEARCA:INFU - NYSE Arca - US45685K1025 - Common Stock - Currency: USD
Taking everything into account, INFU scores 6 out of 10 in our fundamental rating. INFU was compared to 102 industry peers in the Health Care Providers & Services industry. INFU has an excellent profitability rating, but there are some minor concerns on its financial health. INFU is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, INFU could be worth investigating further for growth investing!.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.06% | ||
ROE | 5.78% | ||
ROIC | 7.47% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 6.07% | ||
PM (TTM) | 2.32% | ||
GM | 53.13% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.52 | ||
Debt/FCF | 12.54 | ||
Altman-Z | 2.52 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.21 | ||
Quick Ratio | 1.83 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 42.5 | ||
Fwd PE | 17.43 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 54.54 | ||
EV/EBITDA | 7.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
5.95
-0.16 (-2.62%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 42.5 | ||
Fwd PE | 17.43 | ||
P/S | 0.91 | ||
P/FCF | 54.54 | ||
P/OCF | 5.71 | ||
P/B | 2.26 | ||
P/tB | 2.76 | ||
EV/EBITDA | 7.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.06% | ||
ROE | 5.78% | ||
ROCE | 9.46% | ||
ROIC | 7.47% | ||
ROICexc | 7.6% | ||
ROICexgc | 8.58% | ||
OM | 6.07% | ||
PM (TTM) | 2.32% | ||
GM | 53.13% | ||
FCFM | 1.66% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.52 | ||
Debt/FCF | 12.54 | ||
Debt/EBITDA | 1.35 | ||
Cap/Depr | 151.51% | ||
Cap/Sales | 14.23% | ||
Interest Coverage | 250 | ||
Cash Conversion | 102.77% | ||
Profit Quality | 71.76% | ||
Current Ratio | 2.21 | ||
Quick Ratio | 1.83 | ||
Altman-Z | 2.52 |